HU227318B1 - Cosmetical and dematological composition for treating, grooming of psoric skin and scalp - Google Patents
Cosmetical and dematological composition for treating, grooming of psoric skin and scalp Download PDFInfo
- Publication number
- HU227318B1 HU227318B1 HU0001080A HUP0001080A HU227318B1 HU 227318 B1 HU227318 B1 HU 227318B1 HU 0001080 A HU0001080 A HU 0001080A HU P0001080 A HUP0001080 A HU P0001080A HU 227318 B1 HU227318 B1 HU 227318B1
- Authority
- HU
- Hungary
- Prior art keywords
- weight
- oil
- composition
- extract
- preservatives
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 210000004761 scalp Anatomy 0.000 title claims abstract description 5
- 230000003370 grooming effect Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 23
- 239000003921 oil Substances 0.000 claims abstract description 22
- 235000019198 oils Nutrition 0.000 claims abstract description 22
- 239000003755 preservative agent Substances 0.000 claims abstract description 15
- 241000241413 Propolis Species 0.000 claims abstract description 14
- 239000012153 distilled water Substances 0.000 claims abstract description 14
- 229940069949 propolis Drugs 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 12
- 244000305267 Quercus macrolepis Species 0.000 claims abstract description 12
- 235000016976 Quercus macrolepis Nutrition 0.000 claims abstract description 12
- 241000124033 Salix Species 0.000 claims abstract description 12
- 235000009108 Urtica dioica Nutrition 0.000 claims abstract description 12
- 240000008042 Zea mays Species 0.000 claims abstract description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 12
- 239000003925 fat Substances 0.000 claims abstract description 12
- 235000011197 perejil Nutrition 0.000 claims abstract description 12
- 239000010677 tea tree oil Substances 0.000 claims abstract description 12
- 229940111630 tea tree oil Drugs 0.000 claims abstract description 12
- 239000010678 thyme oil Substances 0.000 claims abstract description 12
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 11
- 235000013871 bee wax Nutrition 0.000 claims abstract description 11
- 239000012166 beeswax Substances 0.000 claims abstract description 11
- 240000000662 Anethum graveolens Species 0.000 claims abstract description 10
- 240000009164 Petroselinum crispum Species 0.000 claims abstract description 10
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 239000000654 additive Substances 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims abstract description 5
- 230000001185 psoriatic effect Effects 0.000 claims abstract description 4
- 239000003381 stabilizer Substances 0.000 claims abstract description 4
- 239000004088 foaming agent Substances 0.000 claims abstract 4
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims abstract 2
- 235000003880 Calendula Nutrition 0.000 claims abstract 2
- 240000001432 Calendula officinalis Species 0.000 claims abstract 2
- 244000274883 Urtica dioica Species 0.000 claims abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 26
- 239000004480 active ingredient Substances 0.000 claims description 12
- 235000005979 Citrus limon Nutrition 0.000 claims description 11
- 244000131522 Citrus pyriformis Species 0.000 claims description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 11
- 235000019868 cocoa butter Nutrition 0.000 claims description 11
- 229940110456 cocoa butter Drugs 0.000 claims description 11
- 235000005822 corn Nutrition 0.000 claims description 11
- 240000000073 Achillea millefolium Species 0.000 claims description 10
- 235000007754 Achillea millefolium Nutrition 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 10
- 239000004202 carbamide Substances 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 235000019197 fats Nutrition 0.000 claims description 10
- 230000002008 hemorrhagic effect Effects 0.000 claims description 9
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- 235000021388 linseed oil Nutrition 0.000 claims description 5
- 239000000944 linseed oil Substances 0.000 claims description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 claims description 4
- 229940063953 ammonium lauryl sulfate Drugs 0.000 claims description 4
- 239000002518 antifoaming agent Substances 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- 239000000344 soap Substances 0.000 claims description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 206010029897 Obsessive thoughts Diseases 0.000 claims description 2
- 229930182558 Sterol Natural products 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 150000003432 sterols Chemical class 0.000 claims description 2
- 235000003702 sterols Nutrition 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 244000042664 Matricaria chamomilla Species 0.000 claims 1
- 240000002657 Thymus vulgaris Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- PVFSDGKDKFSOTB-UHFFFAOYSA-K iron(3+);triacetate Chemical compound [Fe+3].CC([O-])=O.CC([O-])=O.CC([O-])=O PVFSDGKDKFSOTB-UHFFFAOYSA-K 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract description 7
- 229940042585 tocopherol acetate Drugs 0.000 abstract description 7
- 241000722941 Achillea Species 0.000 abstract 1
- 235000019501 Lemon oil Nutrition 0.000 abstract 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 abstract 1
- 229940124532 absorption promoter Drugs 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229940092738 beeswax Drugs 0.000 abstract 1
- 230000000887 hydrating effect Effects 0.000 abstract 1
- 239000010501 lemon oil Substances 0.000 abstract 1
- 235000009973 maize Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000012676 herbal extract Substances 0.000 description 16
- 235000005881 Calendula officinalis Nutrition 0.000 description 10
- 240000000785 Tagetes erecta Species 0.000 description 10
- 241000219422 Urtica Species 0.000 description 10
- 239000011833 salt mixture Substances 0.000 description 9
- 239000011703 D-panthenol Substances 0.000 description 8
- 235000004866 D-panthenol Nutrition 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 229960003949 dexpanthenol Drugs 0.000 description 8
- 239000002674 ointment Substances 0.000 description 8
- 201000004681 Psoriasis Diseases 0.000 description 7
- 239000002453 shampoo Substances 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 229940057950 sodium laureth sulfate Drugs 0.000 description 5
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 5
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 229940107161 cholesterol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004872 foam stabilizing agent Substances 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- 241000125205 Anethum Species 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000208317 Petroselinum Species 0.000 description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 2
- 241000246358 Thymus Species 0.000 description 2
- 230000003254 anti-foaming effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- -1 cholesterol Chemical class 0.000 description 2
- 238000005237 degreasing agent Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 239000010090 Psoricur Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960002311 dithranol Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 229940057905 laureth-3 Drugs 0.000 description 1
- RYZCLUQMCYZBJQ-UHFFFAOYSA-H lead(2+);dicarbonate;dihydroxide Chemical compound [OH-].[OH-].[Pb+2].[Pb+2].[Pb+2].[O-]C([O-])=O.[O-]C([O-])=O RYZCLUQMCYZBJQ-UHFFFAOYSA-H 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
A találmány tárgya kozmetikai és bőrgyógyászati készítmény, pszoriázisos bőr, fejbőr kezelésére, ápolására.The present invention relates to cosmetic and dermatological compositions for the treatment and care of psoriatic skin and scalp.
A pszoriázis, más néven pikkelysömör, speciális helyet foglal el a bőrbetegségek között. A betegség leggyakrabban öröklött hajlam és különböző provokáló tényezők hatására alakul ki. Nem fertőz, nem mindig viszket, gyakran spontán elmúlik egy időre, de gyakran visszatér.Psoriasis, also known as psoriasis, occupies a special place among skin diseases. The disease is most often caused by hereditary predisposition and various provocative factors. Not infectious, not always itchy, often spontaneous, but often returning.
Az egészséges ember bőre körülbelül 28 naponta megújul, oly módon, hogy a hámsejtek lassan a bőr mélyebb rétegeiből felfelé áramlanak, eközben elvesztik magjukat és szarusejtekké alakulnak, majd a bőr felszínéről leválnak.The skin of a healthy person is renewed every 28 days, with epithelial cells slowly flowing up from the deeper layers of the skin, losing their nucleus and turning into horn cells and then detaching from the surface of the skin.
Pszoriázis betegség esetében ez a folyamat felgyorsul, és 4-6 nap alatt zajlik le, ezért nem jut idő a normális elszarusodásra. A hámsejtek nem válnak le, ezért egy megvastagodott szarupikkely jön létre, ennek következtében megváltozik az alsóbb bőrrétegek viselkedése, a kisebb erek kiszélesednek, különböző sejtek vándorolnak oda. Ennek a folyamatnak az eredményeként kialakul a pszoriázis jellegzetes képe: a bőr felszínén megjelenő vöröses beszűrődés, amelyet legtöbbször ezüstfehér pikkelyek fednek.In psoriasis, this process is accelerated and takes 4-6 days, so there is no time for normal keratitis. The epithelial cells do not detach, so a thickened cornucopia is formed, as a result of which the behavior of the lower layers of the skin changes, the smaller blood vessels expand, and different cells migrate there. This process results in a distinctive picture of psoriasis: a reddish infiltration on the surface of the skin, which is usually covered with silver-white scales.
Olyan gyógyító eljárás, amely az alapbetegséget gyógyítaná, a mai napig nem létezik. A betegség diagnosztizálását követően azonban számos kezelési mód áll rendelkezésre, amelyekkel a tünetek átmenetileg vagy akár tartósan is szüneteltethetők.To date, there is no cure for the underlying disease. However, once the disease has been diagnosed, there are a number of treatments available that can temporarily or even permanently interrupt the symptoms.
A pszoriázis kezelésére lokális vagy szisztémás terápiás lehetőségek vannak. Ha a betegség nem szövődményes formában jelentkezik, akkor leggyakrabban a lokális terápiát részesítik előnyben.There are local or systemic therapeutic options for treating psoriasis. If the disease is not uncommon, topical therapy is most often preferred.
A lokális terápiában alkalmazott készítmények hatóanyagai között legtöbbször kátrányszármazékokat, szteroidokat (kortikoszteroidok), dithranolt, a pikkelyek eltávolítására szalicilsavtartalmú vazelint vagy valamilyen hidrofil kenőcsöt használnak. Szalicilsavtartalmú kenőcsöt ír le például a T74 460 számon közzétett magyar szabadalmi leírás.Among the active ingredients of topical formulations, tar derivatives, steroids (corticosteroids), dithranol, salicylic acid-containing petroleum jelly or a hydrophilic ointment are most commonly used. An example of a salicylic ointment is described in Hungarian Patent Publication No. T74 460.
Igen gyakori hatóanyag egyes gyógynövények alkoholos-vizes kivonatát (például 212 305 lajstromszámú magyar szabadalmi leírás) vagy egyes növényi magolajokat (lásd P9 700 451 E számú magyar közzétett leírás) tartalmazó kombináció, zsíros krémekben, továbbá alkalmazhatók a terápiában egyes természetes eredetű sók - elsősorban a holt-tengeri só - napfényterápiával kombinálva, illetve legújabban szintetikus D3-vitaminokkal történő kezelést is alkalmaznak, UV-terápiával kiegészítve.A very common active ingredient is a combination of an alcoholic-aqueous extract of some herbs (for example, Hungarian Patent Application No. 212,305) or some vegetable seed oils (see Hungarian Patent Publication No. P9,700,451 E) in fatty creams, and certain salts of natural origin can be used in therapy. Dead Sea Salt - in combination with sunlight therapy or most recently with synthetic vitamin D3 supplementation with UV therapy.
Kereskedelmi forgalomból beszerezhető a Psoricur olaj (gyártó: Unipharma Rt.), mely bizonyos növényi hatóanyagokat és propoliszt tartalmaz, kozmetikai vazelinolajjal és borsmentaolajjal együtt.Psoricur oil (manufactured by Unipharma Rt.) Is commercially available, containing certain herbal active ingredients and propolis together with petroleum jelly cosmetics and peppermint oil.
Felismertük, hogy egyrészt meghatározott gyógynövények vizes-alkoholos kivonatát, ugyancsak meghatározott növényi illóolajokkal és csíraolajokkal, propoliszkivonattal, egyes kationokkal és anionokkal dúsított természetes eredetű sókeverékkel, valamint vitaminokkal kombinálva, és ezeket a hatóanyagokat megfelelően magas koncentrációban természetes zsiradékot tartalmazó samponba vagy kenőcsbe dolgozva olyan készítmény állítható elő, amely az eddigi kipróbálás adatai szerint előre nem várt mértékben eredményesen alkalmazható a pszoriázisos fejbőr, vagy a test más részein lévő pszoriázisos tünetek kezelésére; vagyis lényegesen jobb eredményt érünk el a kombinációval, mint az egyes, fentiekben hivatkozott összetétel típusokkal külön-külön elérhető hatás.We have discovered, on the one hand, the combination of an aqueous alcoholic extract of certain herbs, a natural salt mixture enriched with certain vegetable essential oils and germ oils, propolis extract, certain cations and anions, and vitamins, and combining them with which has proven to be effective in treating psoriatic symptoms in the psoriasis or other parts of the body to an unexpected extent; that is, a significantly better result with the combination than the effect obtained with each of the above-mentioned composition types.
A találmány tárgyát képező készítmény csalán, vérehullató fecskefű, tölgyfakéreg, fűzfakéreg, körömvirág, gyermekláncfűgyökér, kamillavirág, cickafark, kapor és petrezselyem keverékének 0,1-10 tömeg%-os 0,1-8 tömeg% mennyiségű vizes-alkoholos-glicerines kivonatát, 0,1-5,0 tömeg% kakukkfű-, citrom- és teafaolajat, 0,5-8 tömeg% kukoricacsíra-olajat, 0,2-6 tömeg% természetes eredetű, előnyösen sárvári thermálsót, 0,3-10 tömeg% propoliszkivonatot, valamint 0,1-8 tömeg% tokoferolt, tokoferol-acetátot vagy -palmitátot és d-panthenolt tartalmaz hatóanyagként.The composition of the invention comprises 0.1-10% by weight of 0.1-8% by weight water-alcohol glycerol extract of a mixture of nettle, hawthorn, oak bark, willow bark, marigold, dandelion, chamomile flower, dill and parsley, 0.1-5.0% by weight of thyme, lemon and tea tree oil, 0.5-8% by weight of corn germ oil, 0.2-6% by weight of natural salt, preferably Sárvár thermal salt, 0.3-10% by weight of propolis extract and 0.1 to 8% by weight of tocopherol, tocopherol acetate or palmitate and d-panthenol as active ingredient.
A készítmény samponként történő előállítása, a kozmetikai iparból ismert általános segédanyagok, a habzást biztosító 10-60 tömeg% nátrium-lauril-szulfát, ammónium-lauril-szulfát, valamint 2-10 tömeg% habzást elősegítő és stabilizáló anyagok felhasználásával történik.The composition is formulated as a shampoo using general auxiliaries known in the cosmetics industry, 10 to 60% by weight of sodium lauryl sulfate, an ammonium lauryl sulfate, and 2 to 10% by weight of antifoaming and stabilizing agents.
A pszoriázis külsődleges kezelésének egyik kulcspontja a száraz bőr hidratálása, zsírzása. Ennek biztosítására a készítmény 2-25 tömeg% természetes eredetű zsiradékot (kakaóvaj, lenolaj, ricinusolaj), 0,5-10,0 tömeg% méhviaszt, valamint 1-15 tömeg% bőrpuhító és hidratálóanyagot (karbamid, allantoin) tartalmaz.One of the key points in the external treatment of psoriasis is to moisturize and grease dry skin. To ensure this, the composition contains 2-25% by weight of natural fat (cocoa butter, linseed oil, castor oil), 0.5-10.0% by weight of beeswax, and 1-15% by weight of emollients and moisturizers (urea, allantoin).
A találmány alapja, hogy az egyébként külön-külön, egyes készítményekben alkalmazott hatóanyagokat együtt, olyan kombinációban alkalmazza, ahol az egyes komponensek hatása felerősödik, illetve ezt az egyedülálló, 18 hatóanyagból álló kombinációt olyan, a bőr felpuhítását és visszazsírzását elősegítő anyagokkal együtt tartalmazza, amelyek biztosítják, hogy egyrészt a hatóanyagok optimálisan szívódjanak fel, másrészt a samponban lévő felületaktív anyagok okozta zsírvesztést a fejbőrben megakadályozza, visszapótolja.The present invention is based on the combination of the active ingredients, which are otherwise used separately in certain formulations, in a combination where the effects of each component are potentiated, or in a unique combination of 18 active ingredients with softening and degreasing agents which ensure that the active ingredients are optimally absorbed and prevented and replaced by the shampoo fat loss caused by the surfactants in the shampoo.
A találmány lényege tehát közelebbről, hogy a készítmény csalán, vérehullató fecskefű, tölgyfakéreg, fűzfakéreg, körömvirág, gyermekláncfűgyökér, kamillavirág, cickafark, kapor és petrezselyem keverékének 0,1-10 tömeg%-os, 0,1-8 tömeg% mennyiségű vizesalkoholos-glicerines kivonatát, 0,1-5,0 tömeg% kakukkfű-, citrom- és teafaolajat, 0,5-8 tömeg% kukoricacsíra-olajat, 0,2-6 tömeg% természetes eredetű, előnyösen sárvári thermálsót, 0,3-10 tömeg% propoliszkivonatot, valamint 0,1-8 tömeg% tokoferol-acetátot és d-panthenolt tartalmaz hatóanyagként,More particularly, the present invention provides a composition comprising 0.1-10% w / w, 0.1-8% w / w aqueous alcohol, of a mixture of nettle, hawthorn, oak bark, willow bark, marigold, chamomile flower, yarrow, dill and parsley. glycerol extract, 0.1-5.0% by weight of thyme, lemon and tea tree oil, 0.5-8% by weight of corn germ oil, 0.2-6% by weight of natural origin, preferably Sárvár thermal salt, 0.3-10 containing by weight of propolis extract and 0.1 to 8% by weight of tocopherol acetate and d-panthenol as active ingredient,
a) a kozmetikai iparból ismert általános segédanyagok, így 10-60 tömeg% habzást biztosító anyag (például nátrium-lauril-szulfát, ammónium-lauril-szulfát), valamint 2-10 tömeg% habzást elősegítő és stabilizáló anyagok, 2-25 tömeg% természetes eredetű zsiradék(a) general excipients known in the cosmetic industry, such as 10 to 60% by weight of an antifoaming agent (e.g., sodium lauryl sulfate, ammonium lauryl sulfate) and 2 to 10% by weight of antifoaming and stabilizing agents, 2 to 25% by weight fat of natural origin
HU 227 318 Β1 (mint kakaóvaj, lenolaj, ricinusolaj), 0,5-10,0 tömeg% méhviasz, valamint 1-15 tömeg% bőrpuhító és hidratálóanyag (karbamid, allantoin), desztillált víz, továbbá konzerválószer közül választott adalékokkal együtt; vagyEN 227 318 Β1 (such as cocoa butter, linseed oil, castor oil), from 0.5 to 10.0% by weight of beeswax and from 1 to 15% by weight of emollients and moisturizers (urea, allantoin), distilled water and preservatives; obsession
b) önmagában ismert emulgensek, zsírok, állományjavítók, felszívódást elősegítő anyagok, desztillált víz, konzerválószerek közül választott adalékokkal együtt.(b) well-known additives, emulsifiers, fats, conditioners, absorption aids, distilled water, and preservatives.
A találmány alapja, hogy az egyébként külön-külön, egyes készítményekben alkalmazott hatóanyagokat együtt, olyan kombinációban alkalmazza, ahol az egyes komponensek hatása felerősödik, illetve ezt az egyedülálló 18 hatóanyagból álló kombinációt olyan, a bőr felpuhítását és visszazsírzását elősegítő anyagokkal együtt tartalmazza, amelyek biztosítják, hogy egyrészt a hatóanyagok optimálisan szívódjanak fel, másrészt a samponban lévő felületaktív anyagok okozta zsírvesztést a fejbőrben megakadályozza, visszapótolja.The present invention is based on the combination of the active ingredients, which are otherwise used separately in certain formulations, in a combination where the effect of each component is enhanced, or a unique combination of 18 active ingredients with softening and degreasing agents that provide to optimally absorb the active ingredients and to prevent and restore fat loss in the scalp caused by surfactants in the shampoo.
A találmány szerinti megoldást a következőkben a jobb érthetőség kedvéért példákkal szemléltetjük; a példákban a százalékok tömegszázalékot jelentenek.The following examples illustrate the present invention for the sake of clarity; in the examples, the percentages are by weight.
1. példa: SamponExample 1: Shampoo
100,00100.00
Kivonat készítése: vizes-alkoholos kivonószerrel extrahálva.Preparation of extract: extracted with aqueous alcoholic extractant.
2. példa: SamponExample 2: Shampoo
gyógynövényes kivonat (az alább részletezett arányok a kivonat készítése-herbal extract (the ratios detailed below to make the extract-
HU 227 318 Β1HU 227 318 Β1
100,00% gyógynövényes kivonat (az alább részletezett arányok a kivonat készítése-100.00% Herbal Extract (The ratios detailed below to make the extract-
it) gyógynövényes kivonat (az alább részletezett arányok a kivonat készítése kor bemért összetevöarányok)it) herbal extract (proportions of ingredients measured at the time of preparation of the extract)
Csalán 1,00Nettle 1.00
Vérehullató fecskefű 1,00Haemorrhagic haemorrhage 1.00
HU 227 318 Β1HU 227 318 Β1
100,00%100.00%
Kivonat készítése: vizes-alkoholos-glicerines kivonószerrel extrahálva.Preparation of extract: extracted with aqueous alcohol-glycerol extractant.
7. példa: HajbalzsamExample 7: Hair Conditioner
Összetevő Mennyiség (%)Component Quantity (%)
Nátrium-lauril-szulfát 5,00Sodium lauryl sulfate 5.00
Etoxilezett ricinusolaj 2,40Ethoxylated castor oil 2.40
HU 227 318 Β1HU 227 318 Β1
100,00%100.00%
Kivonat készítése: vizes-alkoholos-glicerines kivonószerrel extrahálva.Preparation of extract: extracted with aqueous alcohol-glycerol extractant.
Claims (6)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0001080A HU227318B1 (en) | 2000-03-08 | 2000-03-08 | Cosmetical and dematological composition for treating, grooming of psoric skin and scalp |
PCT/HU2001/000026 WO2001066079A1 (en) | 2000-03-08 | 2001-02-28 | Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care |
AU2001240940A AU2001240940A1 (en) | 2000-03-08 | 2001-02-28 | Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0001080A HU227318B1 (en) | 2000-03-08 | 2000-03-08 | Cosmetical and dematological composition for treating, grooming of psoric skin and scalp |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0001080D0 HU0001080D0 (en) | 2000-05-28 |
HUP0001080A2 HUP0001080A2 (en) | 2002-04-29 |
HU227318B1 true HU227318B1 (en) | 2011-03-28 |
Family
ID=89978167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0001080A HU227318B1 (en) | 2000-03-08 | 2000-03-08 | Cosmetical and dematological composition for treating, grooming of psoric skin and scalp |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001240940A1 (en) |
HU (1) | HU227318B1 (en) |
WO (1) | WO2001066079A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2841134B1 (en) * | 2002-06-25 | 2004-08-20 | Vincience | COMPOSITION COMPRISING A BIOTRANSFORMATION-MODIFIED CORK EXTRACT |
PL355298A1 (en) * | 2002-08-01 | 2004-02-09 | DERMAPHYT Sp.z o.o. | Dermatological preparation for curing skin defects |
DE102005043714A1 (en) * | 2005-09-14 | 2006-04-06 | Föhrdes, Friedhelm | Agent, useful in body and beauty care product, comprises water, ethereal oil and tree extract |
DE102006047733A1 (en) * | 2006-10-06 | 2008-04-10 | Henkel Kgaa | Use of dandelion extract to promote hair thickness and stimulate hair growth |
CN100459972C (en) * | 2006-11-07 | 2009-02-11 | 华南农业大学 | Anti-acne moisturizing cream and preparation process thereof |
BE1017943A4 (en) * | 2007-01-05 | 2010-01-12 | Erbisim Tahir | Psoriasis treatment scalp. |
HUP0700426A2 (en) * | 2007-06-19 | 2010-03-29 | Invencio 21 Gyogyhatasu Keszit | Liposomal compound |
FR2921834B1 (en) * | 2007-10-04 | 2011-08-19 | Trois Chenes | ANTI-OXIDANT AGENT OF PLANT EXTRACTS, AND COSMETIC COMPOSITION COMPRISING SAID AGENT |
IL189569A0 (en) | 2008-02-18 | 2009-02-11 | Mina Faran Dr | Cosmetic and dermatological composition for psoriatic skin treatment |
ITMI20080395A1 (en) * | 2008-03-10 | 2009-09-11 | Indena Spa | FORMULATIONS FOR THE TREATMENT OF VARUCHE AND PSORIATIC PLATES |
DE102009001484A1 (en) * | 2009-03-11 | 2010-09-16 | Henkel Ag & Co. Kgaa | Hair treatment agent with royal jelly |
DE102009026775A1 (en) * | 2009-06-05 | 2010-12-09 | Henkel Ag & Co. Kgaa | Surfactant-containing cosmetic cleanser with royal jelly |
FR2989896B1 (en) * | 2012-04-25 | 2014-04-25 | Oreal | ACTIVE ACHILLA ESSENTIAL OIL FOR THE PREVENTION AND / OR TREATMENT OF SKIN DISORDERS AND / OR CUTANEOUS IMPERFECTIONS |
ES2441267B1 (en) * | 2012-07-31 | 2014-11-12 | Delfín SIERRA GUTIÉRREZ | Hair composition |
US9205042B1 (en) * | 2012-12-31 | 2015-12-08 | Robert Heiman | Lip and skin care product, dispenser and methods |
US10405795B1 (en) | 2013-03-15 | 2019-09-10 | The Procter & Gamble Company | Methods of classifying periorbital dyschromia and systems therefor |
FR3012038B1 (en) | 2013-10-23 | 2015-12-18 | Oreal | ESSENTIAL OIL OF ACHILLEE AS AGENT ANTI-AGE |
CL2014002248A1 (en) * | 2014-08-25 | 2014-10-17 | Muciderm S A | Pharmaceutical composition comprising snail drool helix aspersa müller (5% to 50%), chamomile extract (5% to 10%) and honey (5% to 10%); preparation procedure; use of the composition because it serves to prepare a medicament or device useful for preventing or treating lesions derived from psoriasis. |
CL2014002729A1 (en) * | 2014-10-10 | 2014-12-19 | Muciderm S A | Pharmaceutical composition consisting of snail drool helix aspersa müller (20-50%), chamomile extract (1-4%), propolis (1-4%) and additives and / or excipients, with a viscosity of 10 to 1000 pa- s, in the form of lotion, cream, soap or gel; procedure to obtain it; and its use to prevent or treat pathologies of rosacea. |
US10493020B2 (en) * | 2016-04-14 | 2019-12-03 | The Procter & Gamble Company | Method of improving the appearance of periorbital dyschromia |
CN108143652B (en) * | 2017-12-22 | 2020-11-13 | 广东嘉丹婷日用品有限公司 | Preparation method of composition with skin-care effect and preparation method of shower gel of composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE86114T1 (en) * | 1987-12-23 | 1993-03-15 | Psoricur Ltd | MEDICAL COMPOSITIONS AGAINST PSORIASIS. |
HU203668B (en) * | 1990-04-03 | 1991-09-30 | Tamas Angeli | Cosmetic containing medicinal plants and process for producing composition against psoriasis |
ZA9610264B (en) * | 1995-09-07 | 1998-06-08 | Marie Therese Leon Elza Pretor | Preparation for use in the treatment of skin disorders. |
DE19615293A1 (en) * | 1996-04-18 | 1997-10-23 | Johann Dibart | Propolis skin disorder salve |
DE19729143C2 (en) * | 1997-07-08 | 2000-10-19 | Uwe Fischer | Herbal care ointment |
DE19800982A1 (en) * | 1998-01-14 | 1999-07-15 | Foerster Karl Heinz | Ointment containing ethereal oil, liposomes and vitamins, for treating neurodermatitis, psoriasis and eczema |
-
2000
- 2000-03-08 HU HU0001080A patent/HU227318B1/en not_active IP Right Cessation
-
2001
- 2001-02-28 WO PCT/HU2001/000026 patent/WO2001066079A1/en active Application Filing
- 2001-02-28 AU AU2001240940A patent/AU2001240940A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HU0001080D0 (en) | 2000-05-28 |
AU2001240940A1 (en) | 2001-09-17 |
HUP0001080A2 (en) | 2002-04-29 |
WO2001066079A1 (en) | 2001-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU227318B1 (en) | Cosmetical and dematological composition for treating, grooming of psoric skin and scalp | |
US6221372B1 (en) | Cosmetic cleansing and skin care preparation containing plant and algae extracts | |
JPH08310919A (en) | Hair cosmetic | |
KR102280941B1 (en) | Skin moisturizing and skin soothing cosmetic composition comprising Aloe barbadensis leaf juice and extracts of Pulsatilla koreana, Centella asiatica, Portulaca oleracea and Hamamelis virginiana | |
KR102268243B1 (en) | A hair care composition comprising egg yolk oil | |
JPH0375523B2 (en) | ||
US20100323040A1 (en) | Cosmetic composition for topical use comprising wasabi | |
JP2010505800A (en) | Use of cosmetic compositions to care for oily skin | |
KR101230277B1 (en) | Composition of External Application for Using Bamboo Sprout | |
JP3611128B2 (en) | Testosterone-5-α-reductase inhibitor | |
JP3787566B2 (en) | Cosmetic composition for caring for male skin and hair | |
US10420962B2 (en) | Organic hair formulation and treatment | |
US4833147A (en) | Sebosuppressive compositions and method for suppressing sebaceous gland activity | |
JP5765744B2 (en) | Preventive or therapeutic agent for atopic dermatitis, and external preparation | |
JP4033981B2 (en) | Testosterone 5α-reductase inhibitor | |
US5518722A (en) | Skin regenerating cosmetic composition | |
KR20010018805A (en) | Cosmetic compositions for anti-inflammation and anti-irritation containing ponciri fructus extracts as effective ingredients | |
JPH06271452A (en) | Skin cosmetic containing extract of plant of cactuses | |
KR20110118497A (en) | Cosmetic composition for moisturizing and elasiticity of skin containing the laminaria japonica extract, undaria pinnatifida extract and plantago asiatica seed extract | |
JP2005298503A (en) | Moisture-retention cosmetic composition containing pulverized polygonatum offcinale | |
AU7733401A (en) | Method for promoting clear skin | |
US20010014316A1 (en) | Liquid cleansing composition | |
JP2004510722A (en) | Skin cleansing composition and treatment of acne | |
JPH10279427A (en) | Moisture-retaining cosmetic material composition | |
JPH0656626A (en) | Surfactant-containing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NF4A | Restoration of patent protection | ||
MM4A | Lapse of definitive patent protection due to non-payment of fees |